Showing results (121-130 of 169) with videos related to
Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate CancerRana R McKay, Lillian Werner, Elahe A Mostaghel, et al.Clinical Genitourinary Cancer|January 19, 2016
Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer CenterVinayak Muralidhar, Meredith M Regan, Lillian Werner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancerMing Yang, Wanling Xie, Elahe Mostaghel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2012
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemiaJennifer R Brown, Megan Hanna, Bethany Tesar, et al.Neurosurgery|October 4, 2017
Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case-Control StudyIsabel C Hostettler, Varinder S Alg, Nichole Shahi, et al.The Science of the Total Environment|October 31, 2018
Generation rate and fate of surplus soil extracted in New York CityDaniel Walsh, Isabel McRae, Ryan Zirngibl, et al.The Journal of Allergy and Clinical Immunology|August 25, 2016
IL-4 impairs wound healing potential in the skin by repressing fibronectin expressionAna P M Serezani, Gunseli Bozdogan, Sarita Sehra, et al.Plos One|August 2, 2014
Identification of ALK gene alterations in urothelial carcinomaJoaquim Bellmunt, Shamini Selvarajah, Scott Rodig, et al.Haematologica|May 7, 2013
A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaJennifer R Brown, Bradley Messmer, Lillian Werner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancerMary-Ellen Taplin, Meredith M Regan, Yoo-Joung Ko, et al.Pageof 17